Abstract
AbstractOrganizations worldwide are struggling to cope with the HIV pandemic. They are confronted by a scarcity of resources that is particularly acute in Africa and other developing countries. This chapter focuses on the extent to which economic evaluations can help these organizations deal with fundamental economic constraint. Its discussions draw heavily on experiences in sub-Saharan Africa, as it is the region where the prevalence and impact of HIV have been greatest, and it is where almost all cost-effectiveness research in the less-developed world has been conducted. Nevertheless, the ideas advanced here are relevant for decision makers everywhere concerned about HIV, particularly those in lower-income settings.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
